Jordan Atrial Fibrillation Study

Cross-source consensus on Jordan Atrial Fibrillation Study from 1 sources and 6 claims.

1 sources · 6 claims

Uses

Background

Evidence quality

Highlighted claims

The JoFIB Study is a nationwide, multicentre, prospective observational cohort study enrolling consecutive adult AF patients from 20 hospitals and 30 outpatient cardiology clinics across Jordan. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study
Of 2,020 enrolled patients, 117 (5.8%) were lost to follow-up, leaving 1,903 patients with complete one-year data. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study
The JoFIB cohort was 54.3% female and 45.7% male. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study
Patients were prospectively followed at 1, 6, and 12 months through hospital admissions, outpatient records, and phone calls. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study
The threshold separating oligomorbidity from multimorbidity groups was anchored to the modal number of comorbidities in the Jordanian population. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study
Middle Eastern patients with AF carry a high comorbidity burden, with hypertension, CVD, type II DM, CKD, dyslipidaemia, and chronic lung disease as the predominant comorbid conditions. — The Effect of Multimorbidity and Anticoagulation Use in Patients with Atrial Fibrillation on The One-Year Outcome: Analysis from Jordan Atrial Fibrillation (JoFIB) Study – A Prospective Cohort Study